LOS ANGELES — The median cost of brand-name anti-seizure medications (ASMs) in the United States almost doubled from 2013 to 2023, whereas generic ASM prices declined over the same period, results of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback